Director/PDMR Shareholding (Replacement)

RNS Number : 4444B
GlaxoSmithKline PLC
16 April 2012
 



The 'Director/PDMR Shareholding' announcement for GlaxoSmithKline PLC released on 16 April 2012 at 11.09 under RNS No 3900B has been re-released to facilitate onward transmission by third party vendors.

 

The announcement is unchanged and is reproduced in full below.

 

 

 

 

Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

 

 

The Administrators of the GlaxoSmithKline 2009 Deferred Annual Bonus Plan (the "Plan") notified the Company and the under-mentioned persons on 16 April 2012 of an increase in their notional interests in Ordinary Shares and American Depositary Shares (ADSs) at a price of 1408.5 pence per Ordinary Share and $44.97 per ADS following the re-investment of dividends paid to shareholders on 12 April 2012.

 

 

 

Sir Andrew Witty

Acquisition of 1099 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 1099 Ordinary Shares under the matching element of the Plan (Company contribution).



Mr S M Bicknell

Acquisition of 129 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 129 Ordinary Shares under the matching element of the Plan (Company contribution).



Mrs D P Connelly

Acquisition of 71 ADSs under the personal contribution element of the Plan.




Acquisition of 71 ADSs under the matching element of the Plan (Company contribution).



Mr D S Redfern

Acquisition of 145 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 145 Ordinary Shares under the matching element of the Plan (Company contribution).



Dr M M Slaoui

 

Acquisition of 355 ADSs under the personal contribution element of the Plan.




Acquisition of 355 ADSs under the matching element of the Plan (Company contribution).



Ms C Thomas 

Acquisition of 32 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 32 Ordinary Shares under the matching element of the Plan (Company contribution).



Mr D E Troy

Acquisition of 178 ADSs under the personal contribution element of the Plan.




Acquisition of 178 ADSs under the matching element of the Plan (Company contribution).



Dr P J T Vallance

Acquisition of 288 Ordinary Shares under the personal contribution element of the Plan.

 


Acquisition of 288 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

The notional dividends accrued will be paid out in proportion to the percentage of the participant's deferred annual bonus holdings that will vest following the end of the relevant three year measurement period.

 

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

 

V A Whyte

Company Secretary

 

16 April 2012

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEAXLKFEPAEFF

Companies

GSK (GSK)
UK 100

Latest directors dealings